Publication | Closed Access

Pharmacodynamic Responses to combined treatment regimens with the calcium sensing receptor antagonist JTT-305/MK-5442 and alendronate in osteopenic ovariectomized rats

MedicinePhysiologyPharmacodynamic ResponsesOsteoarthritisReceptor Antagonist Jtt-305/mk-5442PharmacotherapyEndocrinologyPharmacologyOsteoporosisBone MetabolismOsteocalcinTreatment RegimensHealth Sciences